Skip to main content
Pathogens and Global Health logoLink to Pathogens and Global Health
. 2014 Oct;108(7):344–346. doi: 10.1179/2047773214Y.0000000160

Toxoplasmosis in dogs: first report of Toxoplasma gondii infection in any animal species in Angola

Ana Patrícia Lopes 1; 2,2, Sara Granada 3, Ana Cristina Oliveira 3, Hugo Brancal 4; 5; 6,5,6, Jitender P Dubey 7, Luís Cardoso 1; 8,8, Hugo Vilhena 2; 9; 10,9,10
PMCID: PMC4241787  PMID: 25392293

Abstract

Despite the worldwide importance of zoonotic parasite Toxoplasma gondii, nothing is known of toxoplasmosis in animals in Angola. The present study aimed at estimating the seroprevalence and also at assessing correlates of T. gondii infection in pet dogs from Luanda, Angola. Dogs (n = 103) brought to a veterinary clinic in the city of Luanda were investigated. Serum samples were tested for antibodies to T. gondii with a modified agglutination test (MAT) commercial kit, at serial dilutions of 1∶20 to 1∶160. In accordance with the established cutoff value (MAT ≧20), 16 dogs [15.5%; 95% confidence interval (CI): 9.2–24.0%] had antibodies to T. gondii: 10 had a titer of 20, two had a titer of 40, and four had a titer of 80. Age (≧12 months) was found to be a risk factor for infection [odds ratio (OR) = 9.23; 95% CI: 1.16–73.27). For each 1-year increase in age, the risk of a dog being found seropositive significantly increased by an OR of 1.18 (95% CI: 1.02–1.36). The present study, which represents the first serological survey of T. gondii in any animal species from Angola, reveals a 15.5% seroprevalence of infection in pet dogs in Luanda. Further studies are needed to better understand the epidemiology of zoonotic T. gondii infection in Luanda and also in Angola.

Keywords: Angola, Dogs, Luanda, Modified agglutination test, Seroprevalence, Toxoplasma gondii

Introduction

Toxoplasmosis, caused by the protozoan Toxoplasma gondii, is an endemic parasitic zoonosis throughout the world. Subclinical and clinical infections with T. gondii including fatal cases have been described in dogs.1 These animals can be used as sentinels of environmental contamination with T. gondii and viable T. gondii has been isolated from tissues of subclinically infected dogs.24

Because of the preference of dogs to roll on smelly substances, like cat faeces, and of their coprophagous habits, dogs can carry or mechanically spread T. gondii oocysts, thus allowing the transmission of infective forms and contamination of the environment.5,6 Dogs themselves do not produce oocysts of T. gondii, but oocysts ingested from cat faeces by coprophagia can pass through intact in dog faeces, and viable oocysts have been demonstrated in faeces of dogs in Europe.7 Humans can become infected with T. gondii by ingesting oocysts from dog fur while petting them.5 Additionally, the consumption of improperly cooked infected meat can be a supplementary health risk to consumers in countries where dogs serve as food animals.4

Despite the worldwide importance of this zoonotic parasite, limited epidemiological surveys and clinical cases of toxoplasmosis in humans and animals have been reported in the sub-Saharan countries of Africa.1,8 In Angola, we found only two outdated reports on T. gondii infection in humans and no data are provided for animals including dogs.9,10 Angola is located in Middle Africa (UN subregion). The country population is slightly above 20 million inhabitants, with a quarter of them (i.e. five million) living in the capital city of Luanda, which has a mild semi-arid climate, warm to hot but dry. The size of the canine populations both at the city and country levels is not determinable, but a considerable part of the dogs are free-roaming.

The present study aimed at estimating the seroprevalence of T. gondii infection in pet dogs from Luanda, Angola, and also at assessing the main risk factors associated with the presence of specific antibodies in this canine population.

Materials and Methods

Pet dogs (n = 103) brought to a veterinary medical centre in the city of Luanda, Angola, were randomly sampled during January and February 2013. Available categorical data are provided in Table 1. The age of dogs ranged from 3 to 168 months, with an average value of 33 months. For statistical analysis, two age groups were established: one for juvenile (3–11 months) and another for adult dogs (12–168 months) (Table 1). Owners provided their informed consent for inclusion of their animals in the study, which had been approved by the scientific council of the Vasco da Gama University School as complying with the Portuguese legislation for the protection of animals (Law no. 92/1995).

Table 1. Seroprevalence of Toxoplasma gondii infection in dogs from Luanda, Angola.

Variable/category Dogs tested (n) Relative distribution (%) Seropositive dogs (n) Seroprevalence (%) 95% CI
Breed P = 1.0
    Purebred* 88 85.4 14 15.9 9.0–25.2
    Mixed-breed 15 14.6 2 13.3 1.7–40.5
Gender P = 1.0
    Female 42 40.8 7 16.7 7.0–31.4
    Male 61 59.2 9 14.8 7.0–26.2
Age (months) P = 0.028
    3–11 33 33 1 3.0 0.1–15.8
    12–168 67 67 15 22.4 13.1–34.2
Hair length P = 1.0
    Short 58 56.3 9 15.5 7.4–27.4
    Medium or long 45 43.7 7 15.6 6.5–29.5
Housing P = 1.0
    Indoors or mixed 23 22.3 3 13.0 2.8–33.6
    Outdoors 80 77.7 13 16.3 8.9–26.2
Diet P = 0.508
    Commercial 83 80.6 12 14.5 7.7–23.9
    Home-cooked or mixed 20 19.4 4 20.0 5.7–43.7
Travelling P = 1.0
    No 69 67.0 11 15.9 8.2–26.7
    Yes 34 33.0 5 14.7 5.0–31.1
Total 103 100 16 15.5 9.2–24.0

Note: CI: confidence interval.

*32 German Shepherds,12 Rottweilers, 8 Boerboels,7 Labrador Retrievers, 7 Pit Bull-type, 3 Chow Chows, 3 Poodles, 2 Cane Corsos, 2 Shih Tzus and 1 of each: Bernese Mountain Dog, Boxer, Brazilian Mastiff, Bull Terrier, Bullmastiff, Dalmatian, Great Dane, Neapolitan Mastiff, Pekingese, Shar Pei, Weimaraner and Yorkshire Terrier.

Only 100 animals.

Plasma samples were screened for IgG antibodies to T. gondii with a modified agglutination test (MAT) commercial kit (Toxo-Screen DA®; bioMérieux, Lyon, France) following the manufacturer’s instructions. Samples were analysed at the serial dilutions of 1∶20, 1∶40, 1∶80, and 1∶160. A cutoff titre of 20 (i.e. 2 IU/ml in relation to a WHO international reference serum) was chosen to maximize both sensitivity and specificity of the test.11 The commercial test we used is the same as the MAT described by Dubey and Desmonts.12 Among all the serological tests available, the MAT is considered to be the most reliable to detect antibodies to T. gondii in animals, especially in latently infected animals, including dogs.1

The exact binomial test established confidence intervals (CIs) for the partial and total seroprevalence values, with a 95% confidence level. The Chi-square or Fisher’s exact tests were used to compare seroprevalence values among categories of the same independent variables. Variables with a statistically significant difference (P<0.05) between categories were analysed by logistic regression to identify risk factors for seropositivity, calculating odds ratios (ORs) and their 95% CI.13 Analyses were carried out using StatLib and SPSS 21.0 software for Windows.

Results and Discussion

Seroprevalence data are shown in Table 1. Antibodies to T. gondii were found in 16 (15.5%) out of the 103 dogs: 10 had a titer of 20, two a titer of 40, and four a titer of 80. A statistically significant difference was found only for age categories (Table 1). By univariate logistic regression, age ≧12 months was found to be a risk factor for T. gondii infection (OR = 9.23, 95% CI: 1.16–73.27; P = 0.035). Furthermore, for each 1-year increase in age, the risk of a dog being seropositive increased by an OR factor of 1.18 (95% CI: 1.02–1.36; P = 0.022).

The present work revealed antibodies to T. gondii in 15.5% of pet dogs from Luanda, suggesting a considerable degree of exposure to infection. The studied dogs were only client-owned animals and presumably well cared for. Under this circumstance, the prevalence of T. gondii infection in the overall populations of dogs from Luanda and Angola might be higher. Also by using the MAT and a cutoff titre of 25, a seroprevalence value of 90.8% was described in 109 dogs from southwestern Uganda.8 Fifty out of 51 (98.0%) stray dogs from northern Egypt had MAT titres of 25 or higher and viable T. gondii was isolated from 22 out of 43 (51.2%) seropositive dogs bioassayed in mice.4 A seroprevalence of 25.0% was recorded in 168 dogs from northeastern Nigeria examined by the latex agglutination test at a cutoff titre of 64.14 Differences in the canine T. gondii seroprevalence may be due to variable factors, including climate conditions and the lifestyle and behaviour of the studied animals.

In the present study, age ≧12 months was found to be a risk factor for T. gondii infection in dogs. For each 1-year increase in age, the risk of a dog being seropositive increased by an OR of 1.18, suggesting the acquisition of infection due to a longer exposure period with age rather than congenital transmission of T. gondii in the canine population.6 It is assumed that older dogs have more chance to feed on infected food or have contact with the surrounding environment that can be contaminated by T. gondii oocysts.

To the best of our knowledge, this is the first report of T. gondii infection in dogs and in any animal species from Angola. The potentially T. gondii-contaminated environment in Luanda may be responsible for the prevalence of infection detected in dogs. However, further investigations are needed to elucidate the broad epidemiological scenario of T. gondii infection in other animal populations in Angola and to assess its consequences for public health.

Disclaimer Statements

Contributors Concept, design and field studies: HV, SG and ACO. Sample testing and data analysis: APL, HB and LC. Manuscript development and final proof reading: APL, LC and JPD.

Funding This work was sponsored by the Foundation for Science and Technology (FCT), Ministry of Education and Science, Portugal, under the Project PEst-OE/AGR/UI0772/2014.

Conflicts of interest The authors declare no conflict of interest.

Ethics approval The study was approved by the scientific council of the Vasco da Gama University School (Coimbra, Portugal).

References

  • 1.Dubey JP. Toxoplasmosis of animals and humans. 2nd ed. Boca Raton, FL: CRC Press; 2010. [Google Scholar]
  • 2.Meireles LR, Galisteo AJ, Jr, Pompeu E, Andrade HF., Jr Toxoplasma gondii spreading in an urban area evaluated by seroprevalence in free-living cats and dogs. Trop Med Int Health. 2004;9:876–81. doi: 10.1111/j.1365-3156.2004.01280.x. [DOI] [PubMed] [Google Scholar]
  • 3.Salb AL, Barkema HW, Elkin BT, Thompson R, Whiteside DP, Black SR, et al. Dogs as sources and sentinels of parasites in humans and wildlife, northern Canada. Emerg Infect Dis. 2008;14:60–3. doi: 10.3201/eid1401.071113. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.El-Behairy AM, Choudhary S, Ferreira LR, Kwok OC, Hilali M, Su C, et al. Genetic characterization of viable Toxoplasma gondii isolates from stray dogs from Giza, Egypt. Vet Parasitol. 2013;193:25–9. doi: 10.1016/j.vetpar.2012.12.007. [DOI] [PubMed] [Google Scholar]
  • 5.Frenkel JK, Parker BB. An apparent role of dogs in the transmission of Toxoplasma gondii. The probable importance of xenosmophilia. Ann NY Acad Sci. 1986;791:402–7. doi: 10.1111/j.1749-6632.1996.tb53546.x. [DOI] [PubMed] [Google Scholar]
  • 6.Lindsay DS, Dubey JP, Butler JM, Blagburn BL. Mechanical transmission of Toxoplasma gondii oocysts by dogs. Vet Parasitol. 1997;73:27–33. doi: 10.1016/s0304-4017(97)00048-4. [DOI] [PubMed] [Google Scholar]
  • 7.Schares G, Pantchev N, Barutzki D, Heydorn AO, Bauer C, Conraths FJ. Oocysts of Neospora caninum, Hammondia heydorni, Toxoplasma gondii and Hammondia hammondi in faeces collected from dogs in Germany. Int J Parasitol. 2005;35:1525–37. doi: 10.1016/j.ijpara.2005.08.008. [DOI] [PubMed] [Google Scholar]
  • 8.Millán J, Chirife AD, Kalema-Zikusoka G, Cabezón O, Muro J, Marco I, et al. Serosurvey of dogs for human, livestock, and wildlife pathogens, Uganda. Emerg Infect Dis. 2013;19:680–2. doi: 10.3201/eid1904.121143. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Martins J, Abranches P. Infecção toxoplásmica em indivíduos de Huambo, Angola. An Inst Hig Med Trop (Lisb). 1976;4:111–2. [PubMed] [Google Scholar]
  • 10.López R, Contreras R, Font L, Vega O. Presence of antibodies against Toxoplasma gondii in adolescents from the African continent. Rev Latinoam Microbiol. 1992;34:49–52. [PubMed] [Google Scholar]
  • 11.Lopes AP, Santos H, Neto F, Rodrigues M, Kwok OC, Dubey JP, et al. Prevalence of antibodies to Toxoplasma gondii in dogs from northeastern Portugal. J Parasitol. 2011;97:418–20. doi: 10.1645/GE-2691.1. [DOI] [PubMed] [Google Scholar]
  • 12.Dubey JP, Desmonts G. Serological responses of equids fed Toxoplasma gondii oocysts. Equine Vet J. 1987;19:337–9. doi: 10.1111/j.2042-3306.1987.tb01426.x. [DOI] [PubMed] [Google Scholar]
  • 13.Petrie A, Watson P. Statistics for veterinary and animal science. 2nd ed. Oxford: Blackwell Publishing. 2006 [Google Scholar]
  • 14.Kamani J, Mani AU, Kumshe HA, Dogo GI, Yidawi JP, Pauline DK, et al. Serosurvey for Toxoplasma gondii in dogs in Maiduguri, Borno State, Nigeria. J Infect Dev Ctries. 2010;4:16–8. doi: 10.3855/jidc.428. [DOI] [PubMed] [Google Scholar]

Articles from Pathogens and Global Health are provided here courtesy of Taylor & Francis

RESOURCES